ACCUZIDE

This brand name is authorized in Austria, Estonia, Germany, Lithuania, Romania, Turkey.

Active ingredients

The drug ACCUZIDE contains a combination of these active pharmaceutical ingredients (APIs):

1	Quinapril UNII 33067B3N2M - QUINAPRIL HYDROCHLORIDE
	Quinapril is a potent angiotensin-converting enzyme (ACE) inhibitor. The mode of action of quinapril in humans and animals is to inhibit circulating and tissue ACE activity, thereby decreasing vasopressor activity and aldosterone secretion.
	Read more about Quinapril
2	Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE
	Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted.
	Read more about Hydrochlorothiazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09BA06	Quinapril and diuretics	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09B ACE inhibitors, combinations → C09BA ACE inhibitors and diuretics
Discover more medicines within C09BA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00923236, 04627836, 04627865
EE	Ravimiamet	1030105, 1031094, 1074934
LT	Valstybinė vaistų kontrolės tarnyba	1003974, 1003975, 1004178, 1004180, 1019930, 1057643, 1057644, 1082463
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64843001, W64844001, W64845001
TR	İlaç ve Tıbbi Cihaz Kurumu	8681308091123, 8681308091185